- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Acceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary of Merck & C
Total 71 results
-
Acceleron Pharma Inc. (a wholly owned subsidiary...CompletedPulmonary Arterial HypertensionUnited States
-
Acceleron Pharma Inc. (a wholly owned subsidiary...TerminatedCharcot-Marie-Tooth Disease | Facioscapulohumeral Muscular DystrophyUnited States, Spain, Canada
-
Acceleron Pharma Inc. (a wholly owned subsidiary...CompletedOsteoporosisUnited States
-
Acceleron Pharma Inc. (a wholly owned subsidiary...TerminatedDuchenne Muscular DystrophyCanada
-
Acceleron Pharma Inc. (a wholly owned subsidiary...Terminated
-
Acceleron Pharma Inc. (a wholly owned subsidiary...TerminatedAdvanced Renal Cell CarcinomaUnited States
-
Acceleron Pharma Inc. (a wholly owned subsidiary...CompletedSquamous Cell Carcinoma of the Head and NeckUnited States
-
Acceleron Pharma Inc. (a wholly owned subsidiary...TerminatedCharcot-Marie-Tooth DiseaseUnited States
-
Acceleron Pharma Inc. (a wholly owned subsidiary...CompletedAdvanced Adult Hepatocellular CarcinomaUnited States
-
Acceleron Pharma Inc. (a wholly owned subsidiary...Completed
-
Acceleron Pharma Inc. (a wholly owned subsidiary...Completed
-
Acceleron Pharma Inc. (a wholly owned subsidiary...CompletedB-ThalassemiaItaly, Greece
-
Acceleron Pharma Inc. (a wholly owned subsidiary...CompletedMultiple Myeloma | Advanced Solid TumorsUnited States
-
Acceleron Pharma Inc. (a wholly owned subsidiary...Completed
-
Acceleron Pharma Inc. (a wholly owned subsidiary...CompletedPulmonary Arterial HypertensionSpain, United States, Israel, Australia, Germany, United Kingdom, France, Brazil
-
Acceleron Pharma Inc. (a wholly owned subsidiary...TerminatedFacioscapulohumeral Muscular DystrophyUnited States, Spain, Canada
-
Acceleron Pharma Inc. (a wholly owned subsidiary...Completed
-
Acceleron Pharma Inc. (a wholly owned subsidiary...Completed
-
Acceleron Pharma Inc. (a wholly owned subsidiary...Completed
-
Acceleron Pharma Inc. (a wholly owned subsidiary...Completed
-
Acceleron Pharma Inc. (a wholly owned subsidiary...Completed
-
CelgeneAcceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme...CompletedBeta-Thalassemia | Erythrocyte TransfusionUnited States, Israel, Australia, Turkey, Taiwan, Malaysia, United Kingdom, Canada, Thailand, France, Lebanon, Italy, Bulgaria, Greece, Tunisia
-
CelgeneAcceleron Pharma Inc. (a wholly owned subsidiary of Merck Sharp and Dohme...CompletedMyelodysplastic SyndromesCanada, United States, Germany, Belgium, France, United Kingdom, Turkey, Spain, Italy, Netherlands, Sweden
-
ArQule, Inc. (a wholly owned subsidiary of Merck...Terminated
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedAdvanced Solid TumorsUnited States, Italy
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedSolid TumorUnited States, Italy
-
ArQule, Inc. (a wholly owned subsidiary of Merck...Completed
-
ArQule, Inc. (a wholly owned subsidiary of Merck...Completed
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedRenal Cell Carcinoma (RCC) | Alveolar Soft Part Sarcoma (ASPS) | Clear Cell Sarcoma (CCS)United States, Canada, United Kingdom
-
ArQule, Inc. (a wholly owned subsidiary of Merck...Completed
-
ArQule, Inc. (a wholly owned subsidiary of Merck...Completed
-
ArQule, Inc. (a wholly owned subsidiary of Merck...No longer availableGrowth Disorders | Proteus Syndrome | PIK3CA-Related Overgrowth Spectrum (PROS)
-
ArQule, Inc. (a wholly owned subsidiary of Merck...TerminatedOvarian Cancer | Endometrial Cancer | Solid TumorsUnited States
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedSolid Tumor | Tumor | Malignant LymphomaUnited States
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedCholangiocarcinoma | Intrahepatic Cholangiocarcinoma | Mixed Hepatocellular CholangiocarcinomaUnited States, Italy
-
ArQule, Inc. (a wholly owned subsidiary of Merck...Withdrawn
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedUnresectable Hepatocellular CarcinomaBelgium, Italy, United States, Germany, Canada
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedCancer, Advanced Solid TumorsUnited Kingdom
-
ArQule, Inc. (a wholly owned subsidiary of Merck...Completed
-
ArQule, Inc. (a wholly owned subsidiary of Merck...Completed
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedAdenocarcinoma | Pancreatic CancerUnited States
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedHead and Neck Neoplasms | Carcinoma, Squamous CellUnited States
-
ArQule, Inc. (a wholly owned subsidiary of Merck...Terminated
-
ArQule, Inc. (a wholly owned subsidiary of Merck...Completed
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedMetastatic Non-Small Cell Lung CancerUnited States
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedNon Small Cell Lung CancerUnited States, Poland, Germany, Russian Federation, Latvia, Ukraine
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedAdvanced Solid TumorsUnited States
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedHepatocellular Carcinoma | CirrhosisSpain, United States, Italy
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedMetastatic Solid Tumors, Refractory/Relapsed Hematologic MalignanciesUnited States
-
ArQule, Inc. (a wholly owned subsidiary of Merck...CompletedAdvanced Solid TumorsUnited States